Literature DB >> 28288114

Disruption of the ATXN1-CIC complex causes a spectrum of neurobehavioral phenotypes in mice and humans.

Hsiang-Chih Lu1,2, Qiumin Tan2,3, Maxime W C Rousseaux2,3, Wei Wang2,3, Ji-Yoen Kim2,3, Ronald Richman2,3,4, Ying-Wooi Wan2,3, Szu-Ying Yeh1,2, Jay M Patel5, Xiuyun Liu2,3,4, Tao Lin2,6, Yoontae Lee2,3, John D Fryer2,3, Jing Han2,3, Maria Chahrour3, Richard H Finnell7, Yunping Lei7, Maria E Zurita-Jimenez7, Priyanka Ahimaz8, Kwame Anyane-Yeboa8, Lionel Van Maldergem9, Daphne Lehalle10,11,12, Nolwenn Jean-Marcais10,11, Anne-Laure Mosca-Boidron10,11,12,13, Julien Thevenon10,11,12, Margot A Cousin14,15, Della E Bro14,16, Brendan C Lanpher14,16, Eric W Klee14,15,16, Nora Alexander17, Matthew N Bainbridge3,18,19, Harry T Orr20,21, Roy V Sillitoe1,2,5,6, M Cecilia Ljungberg2,22, Zhandong Liu2,22, Christian P Schaaf2,3,23, Huda Y Zoghbi1,2,3,4,5,22.   

Abstract

Gain-of-function mutations in some genes underlie neurodegenerative conditions, whereas loss-of-function mutations in the same genes have distinct phenotypes. This appears to be the case with the protein ataxin 1 (ATXN1), which forms a transcriptional repressor complex with capicua (CIC). Gain of function of the complex leads to neurodegeneration, but ATXN1-CIC is also essential for survival. We set out to understand the functions of the ATXN1-CIC complex in the developing forebrain and found that losing this complex results in hyperactivity, impaired learning and memory, and abnormal maturation and maintenance of upper-layer cortical neurons. We also found that CIC activity in the hypothalamus and medial amygdala modulates social interactions. Informed by these neurobehavioral features in mouse mutants, we identified five individuals with de novo heterozygous truncating mutations in CIC who share similar clinical features, including intellectual disability, attention deficit/hyperactivity disorder (ADHD), and autism spectrum disorder. Our study demonstrates that loss of ATXN1-CIC complexes causes a spectrum of neurobehavioral phenotypes.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28288114      PMCID: PMC5374026          DOI: 10.1038/ng.3808

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  49 in total

1.  ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology.

Authors:  Yung C Lam; Aaron B Bowman; Paymaan Jafar-Nejad; Janghoo Lim; Ronald Richman; John D Fryer; Eric D Hyun; Lisa A Duvick; Harry T Orr; Juan Botas; Huda Y Zoghbi
Journal:  Cell       Date:  2006-12-29       Impact factor: 41.582

2.  SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat.

Authors:  E N Burright; H B Clark; A Servadio; T Matilla; R M Feddersen; W S Yunis; L A Duvick; H Y Zoghbi; H T Orr
Journal:  Cell       Date:  1995-09-22       Impact factor: 41.582

3.  Mice lacking ataxin-1 display learning deficits and decreased hippocampal paired-pulse facilitation.

Authors:  A Matilla; E D Roberson; S Banfi; J Morales; D L Armstrong; E N Burright; H T Orr; J D Sweatt; H Y Zoghbi; M M Matzuk
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

Review 4.  Neuroimaging in autism spectrum disorder: brain structure and function across the lifespan.

Authors:  Christine Ecker; Susan Y Bookheimer; Declan G M Murphy
Journal:  Lancet Neurol       Date:  2015-04-16       Impact factor: 44.182

5.  Progressive impairment of developing neuroendocrine cell lineages in the hypothalamus of mice lacking the Orthopedia gene.

Authors:  D Acampora; M P Postiglione; V Avantaggiato; M Di Bonito; F M Vaccarino; J Michaud; A Simeone
Journal:  Genes Dev       Date:  1999-11-01       Impact factor: 11.361

6.  6p22.3 deletion: report of a patient with autism, severe intellectual disability and electroencephalographic anomalies.

Authors:  Daniela Di Benedetto; Giuseppa Di Vita; Corrado Romano; Mariangela Lo Giudice; Girolamo Aurelio Vitello; Marinella Zingale; Lucia Grillo; Lucia Castiglia; Sebastiano Antonino Musumeci; Marco Fichera
Journal:  Mol Cytogenet       Date:  2013-01-17       Impact factor: 2.009

7.  Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes.

Authors:  Hsiao-Tuan Chao; Hongmei Chen; Rodney C Samaco; Mingshan Xue; Maria Chahrour; Jong Yoo; Jeffrey L Neul; Shiaoching Gong; Hui-Chen Lu; Nathaniel Heintz; Marc Ekker; John L R Rubenstein; Jeffrey L Noebels; Christian Rosenmund; Huda Y Zoghbi
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

8.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

9.  Structure, function, and plasticity of hippocampal dentate gyrus microcircuits.

Authors:  Peter Jonas; John Lisman
Journal:  Front Neural Circuits       Date:  2014-09-10       Impact factor: 3.492

10.  WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013.

Authors:  Jing Wang; Dexter Duncan; Zhiao Shi; Bing Zhang
Journal:  Nucleic Acids Res       Date:  2013-05-23       Impact factor: 16.971

View more
  52 in total

1.  De novo variants in FBXO11 cause a syndromic form of intellectual disability with behavioral problems and dysmorphisms.

Authors:  Sandra Jansen; Ilse M van der Werf; A Micheil Innes; Alexandra Afenjar; Pankaj B Agrawal; Ilse J Anderson; Paldeep S Atwal; Ellen van Binsbergen; Marie-José van den Boogaard; Lucia Castiglia; Zeynep H Coban-Akdemir; Anke van Dijck; Diane Doummar; Albertien M van Eerde; Anthonie J van Essen; Koen L van Gassen; Maria J Guillen Sacoto; Mieke M van Haelst; Ivan Iossifov; Jessica L Jackson; Elizabeth Judd; Charu Kaiwar; Boris Keren; Eric W Klee; Jolien S Klein Wassink-Ruiter; Marije E Meuwissen; Kristin G Monaghan; Sonja A de Munnik; Caroline Nava; Charlotte W Ockeloen; Rosa Pettinato; Hilary Racher; Tuula Rinne; Corrado Romano; Victoria R Sanders; Rhonda E Schnur; Eric J Smeets; Alexander P A Stegmann; Asbjørg Stray-Pedersen; David A Sweetser; Paulien A Terhal; Kristian Tveten; Grace E VanNoy; Petra F de Vries; Jessica L Waxler; Marcia Willing; Rolph Pfundt; Joris A Veltman; R Frank Kooy; Lisenka E L M Vissers; Bert B A de Vries
Journal:  Eur J Hum Genet       Date:  2019-01-24       Impact factor: 4.246

2.  Cerebellar contribution to the cognitive alterations in SCA1: evidence from mouse models.

Authors:  Melissa Asher; Juao-Guilherme Rosa; Orion Rainwater; Lisa Duvick; Michael Bennyworth; Ruo-Yah Lai; Sheng-Han Kuo; Marija Cvetanovic
Journal:  Hum Mol Genet       Date:  2020-01-01       Impact factor: 6.150

3.  Capicua restricts cancer stem cell-like properties in breast cancer cells.

Authors:  Jeehyun Yoe; Donghyo Kim; Sanguk Kim; Yoontae Lee
Journal:  Oncogene       Date:  2020-02-27       Impact factor: 9.867

4.  Rigor and reproducibility in rodent behavioral research.

Authors:  Maria Gulinello; Heather A Mitchell; Qiang Chang; W Timothy O'Brien; Zhaolan Zhou; Ted Abel; Li Wang; Joshua G Corbin; Surabi Veeraragavan; Rodney C Samaco; Nick A Andrews; Michela Fagiolini; Toby B Cole; Thomas M Burbacher; Jacqueline N Crawley
Journal:  Neurobiol Learn Mem       Date:  2018-01-04       Impact factor: 2.877

Review 5.  The Capicua tumor suppressor: a gatekeeper of Ras signaling in development and cancer.

Authors:  Lucía Simón-Carrasco; Gerardo Jiménez; Mariano Barbacid; Matthias Drosten
Journal:  Cell Cycle       Date:  2018       Impact factor: 4.534

6.  Capicua controls Toll/IL-1 signaling targets independently of RTK regulation.

Authors:  Aikaterini Papagianni; Marta Forés; Wanqing Shao; Shuonan He; Nina Koenecke; María José Andreu; Núria Samper; Ze'ev Paroush; Sergio González-Crespo; Julia Zeitlinger; Gerardo Jiménez
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-05       Impact factor: 11.205

7.  CIC Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAF-MEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous System Involvement.

Authors:  Matteo Claudio Da Vià; Antonio Giovanni Solimando; Andoni Garitano-Trojaola; Santiago Barrio; Umair Munawar; Susanne Strifler; Larissa Haertle; Nadine Rhodes; Eva Teufel; Cornelia Vogt; Constantin Lapa; Andreas Beilhack; Leo Rasche; Hermann Einsele; K Martin Kortüm
Journal:  Oncologist       Date:  2019-10-18

8.  ATXN1-CIC Complex Is the Primary Driver of Cerebellar Pathology in Spinocerebellar Ataxia Type 1 through a Gain-of-Function Mechanism.

Authors:  Maxime W C Rousseaux; Tyler Tschumperlin; Hsiang-Chih Lu; Elizabeth P Lackey; Vitaliy V Bondar; Ying-Wooi Wan; Qiumin Tan; Carolyn J Adamski; Jillian Friedrich; Kirk Twaroski; Weili Chen; Jakub Tolar; Christine Henzler; Ajay Sharma; Aleksandar Bajić; Tao Lin; Lisa Duvick; Zhandong Liu; Roy V Sillitoe; Huda Y Zoghbi; Harry T Orr
Journal:  Neuron       Date:  2018-03-08       Impact factor: 17.173

Review 9.  ERK signalling: a master regulator of cell behaviour, life and fate.

Authors:  Hugo Lavoie; Jessica Gagnon; Marc Therrien
Journal:  Nat Rev Mol Cell Biol       Date:  2020-06-23       Impact factor: 94.444

10.  Altered Capicua expression drives regional Purkinje neuron vulnerability through ion channel gene dysregulation in spinocerebellar ataxia type 1.

Authors:  Ravi Chopra; David D Bushart; John P Cooper; Dhananjay Yellajoshyula; Logan M Morrison; Haoran Huang; Hillary P Handler; Luke J Man; Warunee Dansithong; Daniel R Scoles; Stefan M Pulst; Harry T Orr; Vikram G Shakkottai
Journal:  Hum Mol Genet       Date:  2020-11-25       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.